Cargando…
ACE2 maybe serve as a prognostic biomarker in breast invasive carcinoma
BACKGROUND: Breast cancer is a frequently occurring malignant tumor in women. Angiotensin‐converting enzyme 2 (ACE2) is widely expressed in most organs; however, the association of ACE2 with prognosis and immune infiltration in breast invasive carcinoma (BRCA) remains elusive. METHODS: We explored t...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169220/ https://www.ncbi.nlm.nih.gov/pubmed/35373393 http://dx.doi.org/10.1002/jcla.24362 |